Contraindications
These include:
- patients with chronic malabsorption syndrome or cholestasis
- women who are breast-feeding
- not recommended for use in pregnancy or childhood
- the manufacturers of orlistat advise that it should not be prescribed with acarbose
Check the SPC before prescribing this drug
Reference
- Chakhtoura M et al. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. Lancet Review Volume 58. 101882 April 2023
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.